Drug Discovery & Development |
EFSD, JDRF and Lilly Extend Collaboration Supporting Type 1 ...
Drug Discovery & Development The European Foundation for the Study of Diabetes (EFSD), JDRF and Eli Lilly and Company (NYSE: LLY) have agreed to extend their collaboration for the European Programme in Type 1 Diabetes Research through 2020. The programme, which began in 2015 ... EFSD, JDRF, Lilly Extend Collaboration Supporting Type 1 Diabetes ... |
from diabetes - Google News
Social Plugin